Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Returns
Return on equity-242.1%-40.0pp-202.1%-28.7pp-173.4%-13.6pp-159.8%-5.9pp-153.9%-0.5pp
Return on invested capital-290.8%-43.2pp-247.5%-27.6pp-219.9%-3.8pp-216.1%-0.5pp-215.5%+5.9pp
Liquidity
Current ratio33.8×-6.7×40.4×-7.1×47.5×-6.2×53.7×-3.6×57.3×-5.0×
Leverage
Debt-to-equity0.4×0.0×0.3×0.0×0.3×0.0×0.3×0.0×0.2×0.0×
Per Share
Book value per share$34.48-9.2%$37.96-11.5%$42.88-2.2%$43.83+0.2%$43.74+1.3%
Valuation
Market capitalization$50.86B+33.3%$38.16B+23.7%$30.84B+3.9%$29.68B+3.7%$28.63B+4.6%
Price / book31.8×+9.7×22.1×+5.9×16.2×+0.6×15.6×0.0×15.5×+0.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Revolution Medicines, Inc.'s ratios come from?
Every ratio is computed from Revolution Medicines, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.